Ashleigh Hooimeyer

7PUBLICATIONS
9CO-AUTHORS
International accountingPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Predictive and prognostic markersCommunications and media policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 04, 2026
Pharmaceutical Industry Payments to Patient Groups in Australia: A Longitudinal Analysis of a Decade of Disclosures.

|Feb 20, 2026
Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta-analysis.

Ashleigh Hooimeyer, Eliza J McEwin, Zhicheng Wang

|Aug 04, 2025
How does the Content and Dissemination of Communications on the Risks of Medicines Affect Prescriber Awareness, Knowledge, and Behaviour: A Systematic Review.

Lucy T Perry, Annim Mohammad, Ashleigh Hooimeyer

|Jun 25, 2025
Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators.

Lucy T Perry, Alice Bhasale, Ashleigh Hooimeyer

|Jan 13, 2025
Post-Market Evidence for Cancer Medicines in Regulatory and Clinical Decision-Making: A Scoping Review.

Eliza J McEwin, Ashleigh Hooimeyer, Barbara J Mintzes

|May 31, 2023
Conflict of interest policies at Australian medical schools.

Ashleigh Hooimeyer, Travis Lines, Janet Mirzaei

Pageof 2

Frequent Collaborators

6 joint publications

Barbara Mintzes

4 joint publications

Annim Mohammad

3 joint publications

Lucy T Perry

3 joint publications

Eliza J McEwin